bioAffinity (BIAF) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

bioAffinity Revenue Highlights


0

Latest Revenue (Q)

$2.41B

Main Segment (Y)

Other Revenues

bioAffinity Revenue by Period


bioAffinity Revenue by Year

DateRevenueChange
2023-12-31--100.00%
2022-12-31$4.80K100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

bioAffinity generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

bioAffinity Revenue by Quarter

DateRevenueChange
2024-03-31$2.41B108621.37%
2023-12-31$2.21M641.53%
2023-09-30$298.48K1412.23%
2023-06-30$19.74K2043.11%
2023-03-31$921.00-60.74%
2022-12-31$2.35K104.00%
2022-09-30$1.15K-11.94%
2022-06-30$1.31K100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31--

bioAffinity generated $2.41B in revenue during Q1 2024, up 108621.37% compared to the previous quarter, and up 102574211.42% compared to the same period a year ago.

bioAffinity Revenue Breakdown


bioAffinity Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23
Health Care, Other$19.32K
Other Revenues$21.52K

bioAffinity's latest annual revenue breakdown by segment (product or service), as of Dec 23: Other Revenues (52.68%), and Health Care, Other (47.32%).

Quarterly Revenue by Product

Product/ServiceJun 24Mar 24Dec 23Sep 23Jun 23
Other Revenues$23.92K$427.00---
Health Care, Other$33.19K$16.06K$16.93K$2.39K-
Laboratory Services---$7.42K-
Royalty Income---$5.41K-
Health Care, Patient Service---$248.65K-
Diagnostic Test----$7.00K

bioAffinity's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Health Care, Other (58.12%), and Other Revenues (41.88%).

bioAffinity Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
GTHGenetron$650.71M$201.32M
BIOCBiocept$25.86M$589.00K
PMDPsychemedics$22.10M$5.36M
PRPOPrecipio$12.40M$3.43M
GENEGenetic$8.69M$3.96M
TTOOT2 Biosystems$7.19M$1.95M
HTGMHTG Molecular Diagnostics$6.37M$1.03M
INBSIntelligent Bio Solutions$1.26M$823.80K
SQLSeqLL$1.18K-
BIAFbioAffinity-$2.41B

BIAF Revenue FAQ


bioAffinity's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $4.8K, representing an increase of 100.00% compared to 2021. BIAF's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

bioAffinity's quarterly revenue for Q1 2024 was $2.41B, a 108621.37% increase from the previous quarter (Q4 2023), and a 261280138.87% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $2.21M, a 641.53% increase from the previous quarter (Q3 2023), and a 94245.95% increase year-over-year (Q4 2022). BIAF's quarterly revenue for Q3 2023 was $298.48K, a 1412.23% increase from the previous quarter (Q2 2023), and a 25855.13% increase year-over-year (Q3 2022).

bioAffinity's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.

bioAffinity's revenue streams in c 23 are Health Care, Other, and Other Revenues. Health Care, Other generated $19.32K in revenue, accounting 47.32% of the company's total revenue Other Revenues generated $21.52K in revenue, accounting 52.68% of the company's total revenue

For the fiscal year ending Dec 23, the largest source of revenue of bioAffinity was Other Revenues. This segment made a revenue of $21.52K, representing 52.68% of the company's total revenue.